Published in Blood on June 01, 1985
Characterization of a human hematopoietic progenitor cell capable of forming blast cell containing colonies in vitro. J Clin Invest (1988) 1.16
ACP Broadsheet No 134: December 1992. How to harvest bone marrow for transplantation. J Clin Pathol (1992) 0.81
Cyclophosphamides as hypoxia-activated diffusible cytotoxins: a theoretical study. J Comput Aided Mol Des (2000) 0.75
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science (1997) 18.10
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature (1997) 15.49
Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet (2001) 13.32
Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med (1991) 12.09
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med (1992) 6.06
Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N Engl J Med (1982) 5.72
Incidence of polyene-resistant yeasts recovered from clinical specimens. Antimicrob Agents Chemother (1980) 4.53
Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group. N Engl J Med (2000) 4.50
Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology (2000) 3.89
Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med (1987) 3.58
A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. AIDS (1998) 3.54
Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat Med (1997) 3.44
Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Antimicrob Agents Chemother (1993) 3.25
Acyclovir prophylaxis of herpes-simplex-virus infections. N Engl J Med (1981) 3.19
Statistical models for prevalent cohort data. Biometrics (1993) 3.16
Unrecognized human immunodeficiency virus infection in emergency department patients. N Engl J Med (1988) 3.08
Effect of HIV antibody disclosure on subsequent sexual activity in homosexual men. AIDS (1987) 3.01
Candida tropicalis: a major pathogen in immunocompromised patients. Ann Intern Med (1979) 2.71
Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med (1991) 2.59
A survey of Epstein-Barr virus DNA in lymphoid tissue. Frequent detection in Hodgkin's disease. Am J Clin Pathol (1989) 2.48
Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med (1986) 2.47
Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence. AIDS (2000) 2.37
Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 2.36
Venoocclusive disease of the liver following bone marrow transplantation. Transplantation (1987) 2.35
Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. Blood (2001) 2.35
Thalidomide for the treatment of chronic graft-versus-host disease. N Engl J Med (1992) 2.31
A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology (1997) 2.30
Factors associated with prevalent human immunodeficiency virus (HIV) infection in the Multicenter AIDS Cohort Study. Am J Epidemiol (1987) 2.29
Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapy. Lancet (1982) 2.28
Minimum size of the acquired immunodeficiency syndrome (AIDS) epidemic in the United States. Lancet (1986) 2.28
Initial effect of injury on ketone bodies and other blood metabolites. Lancet (1975) 2.27
Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases. Am J Med (1988) 2.19
The value of fungal surveillance cultures as predictors of systemic fungal infections. J Infect Dis (1980) 2.10
Effects of mid-point imputation on the analysis of doubly censored data. Stat Med (1992) 2.09
Visual memory predicts Alzheimer's disease more than a decade before diagnosis. Neurology (2003) 2.06
Use of cyclosporin A in allogeneic bone marrow transplantation in the rat. Nature (1979) 1.90
Corynebacterium sepsis in oncology patients. Predisposing factors, diagnosis, and treatment. JAMA (1977) 1.90
Prevalence of dementia after age 90: results from the 90+ study. Neurology (2008) 1.88
Fc receptors induced by herpes simplex virus. I. Biologic and biochemical properties. J Immunol (1978) 1.85
Predictors of death from chronic graft-versus-host disease after bone marrow transplantation. Blood (1989) 1.85
Fatal disseminated candidiasis due to amphotericin-B-resistant Candida guilliermondii. Ann Intern Med (1985) 1.84
Increased incidence of fungemia caused by Candida krusei. J Clin Microbiol (1986) 1.82
Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1987) 1.82
Semi-automated entry of clinical temporal-abstraction knowledge. J Am Med Inform Assoc (1999) 1.81
Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med (1983) 1.75
Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. Arch Neurol (1996) 1.74
Tool support for authoring eligibility criteria for cancer trials. Proc AMIA Symp (1999) 1.73
Reliability of the Blessed Telephone Information-Memory-Concentration Test. J Geriatr Psychiatry Neurol (1995) 1.72
HLA-restricted cytotoxic T lymphocyte and nonthymic cytotoxic lymphocyte responses to cytomegalovirus infection of bone marrow transplant recipients. J Immunol (1981) 1.69
Colonization and infection with Trichosporon species in the immunosuppressed host. J Infect Dis (1983) 1.69
US nephrologists' recommendation of dialysis modality: results of a national survey. Am J Kidney Dis (2000) 1.65
Cyclosporin A and the thymus. Immunopathology. Am J Pathol (1987) 1.65
Infectious gastroenteritis in bone-marrow-transplant recipients. N Engl J Med (1982) 1.64
Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia. Am J Med (1986) 1.64
Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma. J Clin Oncol (1998) 1.64
Cytosine arabinoside induced gastrointestinal toxic alterations in sequential chemotherapeutic protocols: a clinical-pathologic study of 33 patients. Cancer (1978) 1.63
Modelling paired survival data with covariates. Biometrics (1989) 1.59
Factors influencing the age at natural menopause. J Chronic Dis (1987) 1.57
Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation. Cancer Chemother Pharmacol (1989) 1.57
Septic reactions to platelet transfusions. A persistent problem. JAMA (1991) 1.55
Evaluation of human immunodeficiency virus seroprevalence in population surveys using pooled sera. J Clin Microbiol (1989) 1.54
Detection and significance of alpha granule membrane protein 140 expression on platelets collected by apheresis. Transfusion (1992) 1.54
Ocular manifestations of graft-vs-host disease. Ophthalmology (1983) 1.50
Serum beta-carotene, vitamins A and E, selenium, and the risk of lung cancer. N Engl J Med (1986) 1.46
BK and JC virus infections in recipients of bone marrow transplants. J Infect Dis (1988) 1.45
Variation in the duration of protection given by screening using the Pap test for cervical cancer. J Clin Epidemiol (1989) 1.44
Suppression of thyrotropin in the low-thyroxine state of severe nonthyroidal illness. N Engl J Med (1985) 1.44
Automation and integration of components for generalized semantic markup of electronic medical texts. Proc AMIA Symp (1999) 1.44
Antiapoptotic herpesvirus Bcl-2 homologs escape caspase-mediated conversion to proapoptotic proteins. J Virol (2000) 1.43
Prevention of hypermenorrhea with leuprolide in premenopausal women undergoing bone marrow transplantation. Am J Hematol (1993) 1.43
The semiautonomous replicon: a molecular model for the oncogenicity of SV40. Cold Spring Harb Symp Quant Biol (1975) 1.42
Association of busulfan area under the curve with veno-occlusive disease following BMT. Bone Marrow Transplant (1996) 1.41
Interpartner reliability of reporting of recent sexual behaviors. Am J Epidemiol (1991) 1.41
Evaluation of merocyanine 540-sensitized photoirradiation as a means to inactivate enveloped viruses in blood products. J Lab Clin Med (1990) 1.41
Electronic clinical trial protocol distribution via the World-Wide Web: a prototype for reducing costs and errors, improving accrual, and saving trees. J Am Med Inform Assoc (1997) 1.41
Comparison of immediate and in-hospital results of conventional balloon and perfusion balloon angioplasty using intracoronary ultrasound. Am J Cardiol (1999) 1.39
Clinical toxicity of cryopreserved bone marrow graft infusion. Blood (1990) 1.38
Two cytotoxic cells in peritoneal cavity of virus-infected mice: antibody-dependent macrophages and nonspecific killer cells. J Immunol (1977) 1.37
HLA-restricted cytotoxic T lymphocytes are an early immune response and important defense mechanism in cytomegalovirus infections. Rev Infect Dis (1984) 1.37
Antibiotic combinations for infections in neutropenic patients. Evaluaton of carbenicillin plus either cephalothin or kanamycin. Cancer (1972) 1.35
Pathogenicity of Candida tropicalis and Candida albicans after gastrointestinal inoculation in mice. Infect Immun (1980) 1.34